Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
Viking Therapeutics(VKTX) The Motley Fool·2024-12-21 11:26The weight-loss biotech Viking Therapeutics (VKTX 1.83%) saw its stock get absolutely slammed on Dec. 18, falling 18% as a result of a new move announced by Merck (MRK -1.48%).Given that Viking doesn't yet have any products approved for sale, is this the start of the end, or just a rough bump in the road?The market's fears are overblown, but not ungroundedFirst, let's get to the bottom of what Merck did to provoke Viking's stock into tumbling so much and so quickly.Merck just signed a licensing deal with a ...